NORTHERN TRUST CORP - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$41,417
+64.2%
11,5690.0%0.00%
Q1 2023$25,221
-82.3%
11,569
-2.2%
0.00%
Q4 2022$142,339
+58.2%
11,832
-15.0%
0.00%
Q3 2022$90,000
+45.2%
13,925
+2.1%
0.00%
Q2 2022$62,000
-97.5%
13,640
-95.2%
0.00%
Q1 2022$2,443,000
-29.6%
282,378
+16.1%
0.00%
-100.0%
Q4 2021$3,472,000
-30.1%
243,125
+7.7%
0.00%0.0%
Q3 2021$4,964,000
+75.8%
225,831
+7.0%
0.00%
Q2 2021$2,824,000
+5034.5%
211,082
+1055.4%
0.00%
Q4 2018$55,000
-37.5%
18,269
+1.4%
0.00%
Q3 2018$88,00018,0100.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders